Industry Trends

Bemis vs. Amcor: What the Acquisition Actually Means for Your Packaging Specs

Bemis vs. Amcor: What the Acquisition Actually Means for Your Packaging Specs

If you're still sending RFQs to "Bemis" in 2025, you're technically contacting Amcor. But here's what most procurement teams don't realize: the spec sheets, the plant certifications, and sometimes even the product formulations have shifted since the 2019 acquisition. I've rejected three batches in the past 18 months where the root cause traced back to confusion about which standards applied post-merger.

This isn't a corporate history lesson. It's a framework for comparing what you're actually getting when you source flexible packaging or healthcare packaging from the combined entity versus what you might have expected from legacy Bemis operations.

The Comparison Framework

I'm breaking this down across four dimensions that matter for quality compliance:

• Specification continuity (are your old specs still valid?)
• Plant and certification changes
• Barrier film performance consistency
• Healthcare packaging compliance pathways

Why these four? Because in our Q1 2024 quality audit, every packaging-related nonconformance we flagged touched at least one of these areas. We review roughly 200 unique packaging specs annually, and the Bemis-to-Amcor transition created more verification work than any supplier change in the past four years.

Specification Continuity: Legacy Bemis vs. Amcor Standards

People assume the lowest-friction path: same products, new logo, business as usual. What they don't see is that Amcor has consolidated product lines and, in some cases, reformulated materials to align with their global portfolio.

Legacy Bemis approach: Bemis operated with significant regional autonomy. If you had a custom barrier film spec developed with their Neenah, Wisconsin team, that formulation was often plant-specific. Tolerances were negotiated directly, and you'd have a named technical contact who knew your application inside out.

Amcor consolidated approach: Amcor runs a more centralized specification system. The good news? More consistent global availability. The catch? Your legacy spec might have been "harmonized" into a standard product tier that's close but not identical.

In March 2024, we received a batch of 15,000 pouches where oxygen transmission rate was 0.8 cc/m²/day against our 0.5 cc/m²/day spec. Normal tolerance is ±10%. The vendor's response: "This meets the current Amcor specification for this product family." True—but it didn't meet our specification, which had been grandfathered from a 2017 Bemis agreement. We rejected the batch. They redid it. Now every contract explicitly states our OTR requirements rather than referencing "equivalent to previous supply."

Bottom line: If you haven't re-verified your specs against current Amcor documentation since 2021, do it. The product you're ordering may have drifted.

Plant and Certification Changes

This is where the acquisition created genuine confusion. Amcor closed or consolidated several legacy Bemis facilities. If your supplier qualification was tied to a specific plant's certifications, you need to re-qualify.

What changed:

• Some healthcare packaging production consolidated into Amcor's existing medical packaging facilities
• ISO certifications transferred, but audit dates and scope may have shifted
• Site-specific FDA registrations updated (verify at FDA's device registration database)

What stayed consistent:

• Major healthcare-focused facilities maintained continuity (particularly for sharps containers and medical device packaging)
• Food contact certifications generally carried over

I ran a blind audit with our quality team in late 2023: we pulled supplier qualification records for our top five flexible packaging suppliers. Two of the five had outdated plant certifications on file—both former Bemis facilities that had either closed or transferred production. The cost to re-qualify? About $3,200 in audit fees and four weeks of paperwork. The cost if we'd shipped product with invalid supplier qualifications? I don't want to calculate that.

Here's what you need to know: don't assume your 2018 Bemis supplier qualification transfers automatically. Pull current certifications directly from Amcor and verify against your quality management system requirements.

Barrier Film Performance: The Technical Reality

From the outside, barrier films are barrier films. The reality is formulation matters enormously for shelf life and product protection.

Legacy Bemis strength: Bemis built their reputation on customized barrier solutions. Their R&D team would tweak formulations for specific applications—high-moisture environments, extended shelf life requirements, specific seal strengths for medical packaging.

Amcor global portfolio: Amcor brings a massive portfolio of standardized barrier solutions, plus their own R&D depth. For most applications, their standard offerings match or exceed legacy Bemis performance. But (and this is a meaningful but) for highly customized specs, you may find yourself navigating a more formal development process.

The question isn't whether Amcor can deliver equivalent barrier performance—they absolutely can. It's whether the cost and timeline for custom development matches what you experienced with Bemis. Our 2024 experience: a custom barrier film modification that would have taken 8-10 weeks through legacy Bemis channels took 14 weeks through Amcor's development process. The quality was excellent. The timeline required adjusting our launch schedule.

For standard applications: Amcor's consolidated portfolio is genuinely a strength. More validated options, better global consistency.

For custom applications: Budget additional development time. The engineering capability is there; the process is more structured.

Healthcare Packaging Compliance: What Actually Matters

If you're sourcing medical device packaging, sharps containers, or pharmaceutical packaging, compliance pathway matters more than brand name.

People think Amcor acquired Bemis primarily for flexible packaging scale. Actually, Bemis's healthcare packaging expertise was a significant driver—their established relationships with pharmaceutical companies and medical device manufacturers, plus validated cleanroom production capabilities.

What the acquisition preserved:

• Healthcare packaging facilities with existing FDA registrations
• ISO 13485 certifications (verify current status)
• Established device master files and drug master files

What requires verification:

• Whether your specific product is still manufactured at the same site
• Whether any formulation changes require re-validation on your end
• Updated contact information for regulatory affairs support

I went back and forth on whether to raise this with a client in late 2024. They were sourcing medical device pouches under a spec originally qualified with Bemis in 2019. No visible changes to the product. But when I dug into the documentation, the manufacturing site had shifted. We ultimately chose to re-validate rather than assume equivalence. Took six weeks and about $8,000 in testing costs. Was it necessary? Honestly, probably not—the product was functionally identical. But for medical device packaging, "probably fine" isn't a compliance strategy.

Choosing Your Path Forward

Here's where I'll actually give you recommendations rather than the usual "it depends" hedge:

Stick with Amcor (formerly Bemis) if:

• You need global supply chain consistency
• Your applications fit standard barrier film specifications
• You value the combined R&D depth of a $14+ billion packaging company
• You've already invested in supplier qualification and want to maintain continuity

Consider re-evaluating suppliers if:

• Your specs were highly customized to legacy Bemis formulations
• You've experienced quality drift since the acquisition
• Your volume doesn't justify the development timeline for custom solutions
• Regional suppliers offer equivalent performance with faster response times

Regardless of your choice:

• Re-verify all specifications against current Amcor documentation
• Confirm manufacturing site certifications match your quality records
• Update supplier qualification files with post-acquisition information
• Build explicit specification requirements into contracts rather than referencing "equivalent to previous"

The Honest Assessment

The Bemis-Amcor merger created a genuinely stronger global packaging supplier (which, honestly, was the point). For most applications, you're getting better supply chain resilience and equivalent or superior technical capabilities.

What the merger also created: administrative work for quality teams who need to verify that nothing material changed in the transition. That verification isn't optional—it's part of supplier management.

I've rejected about 4% of first deliveries in 2024 due to specification mismatches. That number was 2.5% in 2022. Not all of that increase traces to the Amcor transition, but enough of it does that I'm flagging it here. The products themselves are fine. The documentation and specification alignment need attention.

Trust me on this one: spend the time now to re-qualify rather than discovering mismatches when product is already in your warehouse.